743 related articles for article (PubMed ID: 12934053)
1. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
Insuk SO; Chae MR; Choi JW; Yang DK; Sim JH; Lee SW
Int J Impot Res; 2003 Aug; 15(4):258-66. PubMed ID: 12934053
[TBL] [Abstract][Full Text] [Related]
2. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
[TBL] [Abstract][Full Text] [Related]
3. ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytes.
Sim JH; Yang DK; Kim YC; Park SJ; Kang TM; So I; Kim KW
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G137-44. PubMed ID: 11751167
[TBL] [Abstract][Full Text] [Related]
4. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C modulation of recombinant ATP-sensitive K(+) channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B.
Thorneloe KS; Maruyama Y; Malcolm AT; Light PE; Walsh MP; Cole WC
J Physiol; 2002 May; 541(Pt 1):65-80. PubMed ID: 12015420
[TBL] [Abstract][Full Text] [Related]
6. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
[TBL] [Abstract][Full Text] [Related]
7. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K+ channel.
Yamada M; Isomoto S; Matsumoto S; Kondo C; Shindo T; Horio Y; Kurachi Y
J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):715-20. PubMed ID: 9130167
[TBL] [Abstract][Full Text] [Related]
8. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
Anesthesiology; 2004 Feb; 100(2):338-46. PubMed ID: 14739809
[TBL] [Abstract][Full Text] [Related]
11. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
12. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitric oxide on the Ca2+-activated potassium channels in smooth muscle cells of the human corpus cavernosum.
Lee SW; Kang TM
Urol Res; 2001 Oct; 29(5):359-65. PubMed ID: 11762799
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of ATP-sensitive K(+) channel subunits expressed in mouse portal vein.
Yamamoto T; Takahara K; Inai T; Node K; Teramoto N
Vascul Pharmacol; 2015 Dec; 75():29-39. PubMed ID: 26163942
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotides of sulfonylurea receptors inhibit ATP-sensitive K+ channels in cultured neonatal rat ventricular cells.
Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
Pflugers Arch; 1999 Feb; 437(3):400-8. PubMed ID: 9914396
[TBL] [Abstract][Full Text] [Related]
16. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels.
Blanco-Rivero J; Gamallo C; Aras-López R; Cobeño L; Cogolludo A; Pérez-Vizcaino F; Ferrer M; Balfagon G
Eur J Pharmacol; 2008 Jun; 587(1-3):204-8. PubMed ID: 18471810
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
19. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
Shindo T; Katayama Y; Horio Y; Kurachi Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
